Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: Wright Reports
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Varian Medical Systems Inc receives FDA 510 clearance for ProBeam proton therapy system

Wednesday, 15 Jan 2014 08:30am EST 

Varian Medical Systems Inc:Says it has received FDA 510 clearance for its updated ProBeam proton therapy system.Says its ProBeam system gives clinicians options for delivering dose precisely in order to minimize dose to healthy tissue in the course of delivering proton therapy treatments for cancer.Says its scanning beam technology enables intensity-modulated proton therapy by modulating dose levels on a spot-by-spot basis throughout the treatment area. Irradiations from multiple angles are combined in an optimal manner to improve control of dose distributions.